021315 female pharm Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

physiological effects of estrogen

A
  • enhances skeletal maturation and epiphyseal growth plate closure
  • feedback regulation of gonadotropin release
  • positive effects on bone mass
  • increases clotting
  • changes bile composition (increases saturation of bile with cholesterol-can cause gallstones)
  • increases amt of cervical mucus and water content (facilitates sperm penetration of cervix)
  • promotes endometrial proliferation
  • increases tubal contractility and favors uterine myometrium contractions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

progesterone and estrogen bioavailability

A

low oral bioavailability

half life of minutes due to first pass effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

physiologic effects of progesterone

A
  • decreases frequency of GnRH pulses (suppresses gonadotropin release)
  • decreases estrogen-driven endothemetrial proliferation and leads to development of secretory endomerium
  • changes cervical mucous to scant viscid material (sperm has difficulty penetrating)
  • maintenance of pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

main determinant for onset of menstruation

A

abrupt decline in progesterone at end of cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mestranol is converted by the body to

A

ethinyl estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ethinyl estradiol

A
synthetic estrogen
orally bioavailable (limits first pass effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

uses of estrogen

A

combination oral contraceptives (ethinyl estradiol or mestranol)

postmenopausal hormone replacement (equine estrogens, estradiol)

failure of pituitary fxn and ovarian development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse and toxic effects of estrogen

A
gallbladder disease
oral estrogens increase risk of thromboembolic dis
nausea and vomiting-initial use
breast swelling
migraine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

contraindications to estrogen use

A

pregnancy
estrogen-dependent cancers
undiagnosed uterine bleeding
thromboembolic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clomiphene

A

racemic mixture of two isomers (weak estrogen agonist and potent antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

use of clomiphene

A

induce ovulation (infertility due to anovulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of clomiphene

A

inhibits action of stronger estrogens–inhibiting feedback on pituitary and hypothalamus. increases pulsatile gonadotropin release amplitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

side effects of clomiphene, tamoxifen, raloxifene, aromatase inhibitors

A

hot flashes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SERMs MOA

A

mixed estrogenic and antiestrogenic effects (tissue specific)

it’s anti-estrogenic in breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

use of tamoxifen

A

tx and prevention of breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

raloxifene MOA

A

estrogen agonist in bone

17
Q

use of raloxifene

A

prophylaxis of osteoporosis

breast cancer

18
Q

aromatase inhibitors

A

letrozole
anastrozole
exemestane

19
Q

suicide inhibitor that irreversibly inactivates aromatase

A

exemestane

20
Q

uses of aromatase inhibitors

A

breast cancer

21
Q

medroxyprogesteron

A

progesterone analog

22
Q

norethindrone

A

19 nortestosterone derivative
primarily progestational rather than androgenic activity

ethinyl subsituent at C17 slows hepatic metabolism

23
Q

norgestrel

A

racemic mixture of inactive isomer and active isomer Levonorgestrel

13 ethyl substituent results in more potent progestin with less androgenic activity than norethindrone

24
Q

drospirenone

A

spironolactone analogue

has ANTI-MINERALCORTICOID and progestin activity

25
Q

use of drospirenone

A

pregnancy prevention

emotional and physical symptoms of premenstural dysphoric disorder (to reduce tendency toward edema)

moderate acne vulgaris

26
Q

uses of progestins

A

hormonal contraceptives

post menopausal hormone replacement therapy (with an estrogen b/c want to limit the proliferation that would occur with estrogen alone)

others-secondary amenorrhea, endometrial hyperplasia

27
Q

adverse effects of progestins

A

headache
breakthrough bleeding
androgenic actions-acne, hirsutism

28
Q

mifepristone

A

competitive progesterone receptor modulator. mainly an antagonist

29
Q

use of mifepristone

A

pregnancy termination

30
Q

MOA of mifepristone

A

causes decidual breakdown

sensitizes myometrium to contractile actions of PGs

31
Q

how is mifepristone administered

A

in combo with PG (misoprostol) to ensure expulsion of blastocyst

32
Q

ulipristal

A

selective progesterone receptor modulator

partial agonist

33
Q

use of ulipristal

A

emergency contraception

34
Q

MOA of ulipristal

A

inhibits ovulation by inhibiting LH release which inhibits LH-induced follicular rupture in ovary

35
Q

emergency contraception

A

combined oral contraceptives (levonorgestrel and ethinyl estradiol)

levonorgestrel alone

ulipristal